Loading clinical trials...
Loading clinical trials...
A Prospective Multi-center Study to Investigate the EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC
Conditions
Start Date
March 1, 2017
Primary Completion Date
December 1, 2020
Completion Date
February 1, 2021
Last Updated
January 20, 2017
NCT05692635
NCT04253964
NCT06228482
NCT03753685
NCT02973789
NCT05275374
Lead Sponsor
Jianxing He
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions